TRACY WIEGAND: Open Payments
NPI 1689328106 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 25 payments from 11 companies in 2025. Trend: 2023 $556 · 2024 $1,979 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $207 |
| Arcutis Biotherapeutics, Inc. | 1 | $182 |
| LEO Pharma Inc. | 6 | $146 |
| Amgen Inc. | 4 | $82 |
| Incyte Corporation | 2 | $44 |
| Journey Medical Corporation | 1 | $43 |
| Organon LLC | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| GENZYME CORPORATION | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: Zoryve, BOTOX, ADBRY, Otezla, OPZELURA, VTAMA, SKYRIZI, RINVOQ.
Industry payments across CA — which companies pay providers there.
